Considering this structural heterogeneity between tauopathies, further studies using approaches such as cryo-EM and immuno-EM48 would be important to determine structural and morphological differences between tau seeds isolated from patients with AD, patients with PSP and PS19 mice. This evidence concerns the gene MAPT and Alzheimer disease.